ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Care Management for Patients With Alzheimer Disease and Their Family Caregivers

This study has been completed.

Sponsored by: Agency for Healthcare Research and Quality (AHRQ)
Information provided by: Agency for Healthcare Research and Quality (AHRQ)
ClinicalTrials.gov Identifier: NCT00246896
  Purpose

This is a clinical trial to test the effectiveness of current guideline for the care of older adults with Alzheimer's disease. The study focuses on the primary care setting using a nurse care manager to facilitate guideline-level care. We are hypothesizing that patients who receive guideline-level care will have fewer behavioral problems than those who receive the usual care provided in primary care settings


Condition Intervention
Alzheimer's Disease
Dementia
Behavioral: care management

Genetics Home Reference related topics:   Alzheimer disease   Dementia  

MedlinePlus related topics:   Alzheimer's Caregivers   Alzheimer's Disease   Caregivers   Dementia  

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Single Blind, Active Control, Single Group Assignment, Efficacy Study
Official Title:   A Program of Collaborative Care for Alzheimer Disease

Further study details as provided by Agency for Healthcare Research and Quality (AHRQ):

Primary Outcome Measures:
  • Neuropsychiatric Inventory
  • Cornell Depression in Dementia Scale
  • Activities of Daily Living

Secondary Outcome Measures:
  • Nursing home placement
  • hospitalization

Estimated Enrollment:   220
Study Start Date:   August 2001
Estimated Study Completion Date:   August 2005

Detailed Description:

The specific aim of this proposal is to conduct a four-year randomized controlled clinical trial to test the efficacy of an integrated program of collaborative care as compared to usual care in improving the process and outcomes of care for older adults with dementia in a primary care setting. The program involves three primary components: (1) A comprehensive screening and diagnosis program in which all older adults aged 65 and older from Wishard’s Community Health Centers will be screened for dementia. Patients with evidence of dementia will receive further evaluation to determine an explicit diagnosis. Roudebush VA Medical Center patients aged 65 and older with a diagnosis of dementia will receive further evaluation to determine an explicit diagnosis. (2) A multidisciplinary team approach to care for patients with dementia. This care will be coordinated through a geriatric nurse practitioner or a clinical nurse specialist working in the primary care clinic. The team includes primary care and specialist physicians, psychologist, other health care workers, and relevant social service agencies working to adhere to recommended standards of care for primary care patients with dementia. (3) A proactive longitudinal tracking program in which objective measures of process and outcomes of care are fed back to the collaborative care team so that appropriate changes in the course of therapy can be undertaken.

Although authoritative guidelines for the care of patients with Alzheimer Disease and related disorders have been published, there are no clinical trials that test the impact of close adherence to these guidelines on the outcomes of care for a group of vulnerable older adults in an urban primary care setting. We are hypothesizing that patients with dementia and their caregivers who are exposed to this program will: (1) be more likely to receive the emerging standard of care for dementia, including an explicit diagnosis of dementia and an appropriate level of evaluation, education, and management; (2) be less impaired by psychopathology and behavior disturbances; (3) be less functionally impaired at 1-year and 2-year follow-up.

  Eligibility
Ages Eligible for Study:   65 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • Alzheimers Disease

Exclusion Criteria:

  • Inability to understand English
  • No telephone
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00246896

Locations
United States, Indiana
Indiana University    
      Indianapolis, Indiana, United States, 46202

Sponsors and Collaborators

Investigators
Principal Investigator:     Christopher M. Callahan, M.D.     Indiana University    
  More Information

Publications of Results:

Study ID Numbers:   RO1 HS10884
First Received:   October 28, 2005
Last Updated:   July 26, 2006
ClinicalTrials.gov Identifier:   NCT00246896
Health Authority:   United States: Federal Government

Study placed in the following topic categories:
Delirium, Dementia, Amnestic, Cognitive Disorders
Alzheimer Disease
Central Nervous System Diseases
Neurodegenerative Diseases
Brain Diseases
Dementia
Cognition Disorders
Delirium

Additional relevant MeSH terms:
Mental Disorders
Nervous System Diseases
Tauopathies

ClinicalTrials.gov processed this record on July 03, 2008




Links to all studies - primarily for crawlers